Browse Pet Safety Reports
143,870 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 143,870 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 143,870 FDA veterinary adverse event reports for Cat.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Jan 1, 2025 | Cat | Cat (unknown) | Buprenorphine | Behavioural disorder NOS; Excessive thirst; Sedation; Hyperthermia | Outcome Unknown |
| Jan 1, 2025 | Cat | Cat (other) | Selamectin | Application site alopecia | Outcome Unknown |
| Jan 1, 2025 | Cat | Cat (unknown) | Buprenorphine | Behavioural disorder NOS | Outcome Unknown |
| Jan 1, 2025 | Cat | Cat (unknown) | Florfenicol; Mometasone Furoate; Terb... | Seizure NOS; Vestibular disorder NOS; Labeled drug-species interaction | Outcome Unknown |
| Jan 1, 2025 | Cat | Domestic Shorthair | Bexagliflozin | Tooth disorder; Food refusal; Hyperglycaemia; Polyuria; Polydipsia; Lack of e... | Outcome Unknown |
| Jan 1, 2025 | Cat | Cat (unknown) | Eprinomectin; Praziquantel; Esafoxolaner | Localised hair loss | Outcome Unknown |
| Jan 1, 2025 | Cat | Domestic Shorthair | Bexagliflozin | Ketosis; Lethargy (see also Central nervous system depression in Neurological... | Ongoing |
| Jan 1, 2025 | Cat | Maine Coon, Cat (other) | Frunevetmab | Renal disorder NOS; High blood pressure; Partial lack of efficacy | Ongoing |
| Jan 1, 2025 | Cat | Cat (unknown) | Eprinomectin; Praziquantel; Esafoxolaner | Not eating; Application site hair loss | Outcome Unknown |
| Jan 1, 2025 | Cat | Cat (unknown) | Molidustat Sodium | Lack of efficacy - NOS | Outcome Unknown |
| Jan 1, 2025 | Cat | Domestic Shorthair | Bexagliflozin | Weight loss | Ongoing |
| Jan 1, 2025 | Cat | Cat (other) | Selamectin;Sarolaner | Lethargy (see also Central nervous system depression in Neurological); Squinting | Outcome Unknown |
| Jan 1, 2025 | Cat | Cat (unknown) | Buprenorphine | Behavioural disorder NOS | Outcome Unknown |
| Jan 1, 2025 | Cat | Domestic Shorthair | Frunevetmab | Increased drinking; Diabetes | Ongoing |
| Jan 1, 2025 | Cat | Cat (unknown) | Capromorelin | Hypersalivation | Recovered/Normal |
| Jan 1, 2025 | Cat | Cat (unknown) | Bexagliflozin | Diarrhoea; Vomiting | Ongoing; Recovered/Normal |
| Jan 1, 2025 | Cat | Domestic Shorthair | Bexagliflozin | Diarrhoea | Outcome Unknown |
| Jan 1, 2025 | Cat | Domestic Shorthair | Bexagliflozin | Ketosis; Hyperglycaemia; High pancreatic-specific lipase; Lack of efficacy - ... | Ongoing |
| Jan 1, 2025 | Cat | Cat (unknown) | Molidustat Sodium | Nausea; Lack of efficacy - NOS | Outcome Unknown |
| Jan 1, 2025 | Cat | Domestic Shorthair | Bexagliflozin | Not eating; Unwell; Elevated symmetrical dimethylarginine (SDMA); Elevated cr... | Ongoing |
| Jan 1, 2025 | Cat | Domestic Shorthair | Bexagliflozin | Elevated protein:creatinine ratio; Glucosuria; Weight loss; Ketonuria | Ongoing |
| Jan 1, 2025 | Cat | Cat (unknown) | Buprenorphine | Prolonged anaesthesia | Outcome Unknown |
| Jan 1, 2025 | Cat | Cat (unknown) | Buprenorphine | Nausea; Drooling; Not eating | Recovered/Normal |
| Jan 1, 2025 | Cat | Cat (unknown) | Buprenorphine | Restlessness; Behavioural disorder NOS | Outcome Unknown |
| Jan 1, 2025 | Cat | Domestic Shorthair | Bexagliflozin | Diarrhoea | Ongoing |
| Jan 1, 2025 | Cat | Cat (unknown) | Buprenorphine | Dysphoria; Agitation; Behavioural disorder NOS | Recovered/Normal |
| Jan 1, 2025 | Cat | Domestic Shorthair | Enrofloxacin | Hypotension; Bradycardia | Recovered/Normal |
| Jan 1, 2025 | Cat | Cat (unknown) | Bexagliflozin | Diarrhoea | Ongoing; Recovered/Normal |
| Jan 1, 2025 | Cat | Domestic Shorthair | Lotilaner | Weight gain; Anaemia NOS; Other abnormal test result NOS | Outcome Unknown |
| Jan 1, 2025 | Cat | Cat (unknown) | Bexagliflozin | Unclassifiable adverse event | Outcome Unknown |
| Jan 1, 2025 | Cat | Cat (unknown) | Buprenorphine | Mental impairment NOS; Stupor | Outcome Unknown |
| Jan 1, 2025 | Cat | Cat (unknown) | Buprenorphine | Staring | Outcome Unknown |
| Jan 1, 2025 | Cat | Burmese, Cat (unknown) | Bexagliflozin | Hyperaesthesia; Lethargy (see also Central nervous system depression in Neuro... | Ongoing |
| Jan 1, 2025 | Cat | Domestic Mediumhair | Fluralaner Spot-On Solution | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Jan 1, 2025 | Cat | Domestic Shorthair | Frunevetmab | Fracture; Unable to jump; Ligament rupture; Anaemia NOS | Ongoing |
| Jan 1, 2025 | Cat | Domestic Shorthair | Bexagliflozin | Dental disease; Weight loss | Outcome Unknown |
| Jan 1, 2025 | Cat | Cat (unknown) | Bexagliflozin | Neoplasia NOS; Death by euthanasia | Euthanized |
| Jan 1, 2025 | Cat | Cat (unknown) | Bexagliflozin | Weight loss | Outcome Unknown |
| Jan 1, 2025 | Cat | Cat (unknown) | Buprenorphine | Unclassifiable adverse event | Outcome Unknown |
| Jan 1, 2025 | Cat | Cat (unknown) | Bexagliflozin | Hypoglycaemia | Outcome Unknown |
| Jan 1, 2025 | Cat | Siamese | Eprinomectin; Praziquantel; Esafoxolaner | Pruritus; Hair loss NOS | Recovered/Normal |
| Jan 1, 2025 | Cat | Domestic Shorthair | Frunevetmab | Lack of efficacy - NOS | Ongoing |
| Jan 1, 2025 | Cat | Maine Coon | Frunevetmab | Lack of efficacy - NOS | Outcome Unknown |
| Jan 1, 2025 | Cat | Cat (unknown) | Imidacloprid; Moxidectin | Diabetes; Death | Died |
| Jan 1, 2025 | Cat | Sphynx | Buprenorphine | Behavioural disorder NOS; Hyperactivity | Outcome Unknown |
| Jan 1, 2025 | Cat | Cat (unknown) | Eprinomectin; Praziquantel; Esafoxolaner | Vomiting | Outcome Unknown |
| Jan 1, 2025 | Cat | Domestic Longhair | Frunevetmab | Scratching; Skin scab; Ear infection NOS | Ongoing |
| Jan 1, 2025 | Cat | Cat (unknown) | Milbemycin Oxime | Renal failure; Death | Died |
| Jan 1, 2025 | Cat | Cat (unknown) | Bexagliflozin | Loose stool; Inflammatory bowel disorder; Cystitis | Outcome Unknown |
| Jan 1, 2025 | Cat | Cat (unknown) | Buprenorphine | Hyperthermia | Recovered/Normal |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.